第一单位：
Rare Diseases Department, General Directorate of Health Services, Turkish Ministry of Health, Ankara, Türkiye.;Department of Medical Biochemistry, Sincan Training and Research Hospital, Ankara, Türkiye.
作者：
Hikmet Can,Çubukçu [1]
;
Guilaine,Boursier [2]
;
Solveig,Linko [3]
;
Francisco A,Bernabeu-Andreu [4]
;
Pika,Meško Brguljan [5]
;
Katerina,Tosheska-Trajkovska [6]
;
Duilio,Brugnoni [7]
;
Neda,Milinkovic [8]
;
Andrea,Padoan [9]
;
Marc,Thelen [10]
;
European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Division: Quality, Standards and Regulations, Committee on Accreditation and ISO/CEN standards (C: A/ISO)
作者单位：
Rare Diseases Department, General Directorate of Health Services, Turkish Ministry of Health, Ankara, Türkiye.;Department of Medical Biochemistry, Sincan Training and Research Hospital, Ankara, Türkiye.
[1]
CHU Montpellier, Department of Molecular Genetics and Cytogenomics, National Reference Laboratory of Autoinflammatory Diseases, French National Reference Center of Autoinflammatory Diseases and Amyloidosis (CeRéMAIA), IRMB, INSERM U1183, Univ Montpellier, Montpellier, France.
[2]
Linko Q-Solutions, Helsinki, Finland.
[3]
Servicio Bioquímica - Análisis Clínicos Hospital Universitario Puerta de Hierro, Madrid, Spain.
[4]
Department of Clinical Chemistry, University Clinic for Respiratory and Allergic Diseases, Golnik, Slovenia.
[5]
Department of Medical and Experimental Biochemistry, Faculty of Medicine, University Ss."Kiril and Metodij", Skopje, North Macedonia.
[6]
Central Laboratory for Clinical Chemistry, Spedali Civili, Brescia, Italy.
[7]
Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia.
[8]
Department of Medicine (DIMED), University of Padova and University Hospital of Padova, Padova, Italy.
[9]
SKML, Nijmegen, The Netherlands.;Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
[10]
DOI
10.1515/cclm-2025-0482
PMID
40440607
发布时间
2025-09-03
换一批
